Seizing the policy moment in crop biotech regulation: an interdisciplinary response to the Executive Order on biotechnologyframework for agricultural biotechnology products. In the fall of 2022, the Executive Order called for the identification of areas of ambiguity, gaps, or uncertainties in the regulation of biotechnology (Executive Order, 2022). Despite the fact that genetically engineered crops and products can yield scientific controversy and public contestation (Gordon et al., 2021;Lefebvre et al., 2016;Cummings and Peters, 2022), the Executive Order gives little explicit direction for their development. Appropriate governmental oversight of these products is necessary to assess potential benefits and risks, facilitate international trade, and build public trust (NASEM, 2016). The governance of US crop biotechnology has been in policy flux since genetic engineering was first put forth as a means of addressing challenges in agriculture and food security and is fraught with complexity and controversy. Oversight in the form of policies and frameworks for regulation should assist society in assessing the potential benefits, risks, and other concerns arising from new technologies (Carroll et al., 2016). And public engagement in the processes of development of agricultural biotechnology has the potential to strengthen the credibility of both developers and regulators, while providing a means to address issues related to public trust and socio-cultural concerns (Kjeldaas et al., 2023). However, current regulation lacks the transparency and public deliberation needed to incorporate the views of ...